Nomenclature and diagnosis of seronegative coeliac disease and chronic non-coeliac enteropathies in adults: the Paris consensus. Issue 11 (8th June 2022)

• Record Type: Journal Article
• Authors: Schiepatti, Annalisa; Sanders, David S; Baiardi, Paola; Caio, Giacomo; Ciacci, Carolina; Kaukinen, Katri; Lebwohl, Benjamin; Leffler, Daniel; Malamut, Georgia; Murray, Joseph A; Rostami, Kamran; Rubio-Tapia, Alberto; Volta, Umberto; Biagi, Federico
• Is Part Of: Gut. Volume 71:Issue 11(2022)
• Page Start: 2218
• Page End: 2225
• Publication Date: 2022-06-08
• Subjects: SMALL INTESTINE -- SMALL INTESTINAL BIOPSY -- SMALL BOWEL DISEASE -- MALABSORPTION -- COELIAC DISEASE; Gastroenterology -- Periodicals; 616.33
• DOI: 10.1136/gutjnl-2021-326645
• Languages: English
• ISSNs: 0017-5749

Abstract

Abstract : Objective: Differential diagnosis of villous atrophy (VA) without coeliac antibodies in adults includes seronegative coeliac disease (CD) and chronic enteropathies unrelated to gluten, ie. non-coeliac enteropathies (NCEs). There is currently no international consensus on the nomenclature and diagnostic criteria for these enteropathies. In this work, a Delphi process was conducted to address this diagnostic and clinical uncertainty. Design: An international task force of 13 gastroenterologists from six countries was recruited at the 16th International Coeliac Disease Symposium, Paris, 2019. Between September 2019 and July 2021, a Delphi process was conducted through mail surveys to reach a consensus on which conditions to consider in the differential diagnosis of VA with negative coeliac serology and the clinical diagnostic approaches required for these conditions. A 70% agreement threshold was adopted. Results: Chronic enteropathies characterised by VA and negative coeliac serology can be attributed to two main clinical scenarios: forms of CD presenting with negative serology, which also include seronegative CD and CD associated with IgA deficiency, and NCEs, with the latter recognising different underlying aetiologies. A consensus was reached on the diagnostic criteria for NCEs assisting clinicians in differentiating NCEs from seronegative CD. Although in adults seronegative CD is the most common aetiology in patients with VA and negative serology, discriminating between seronegative CD and NCEs is key to avoid unnecessary lifelong gluten-free diet, treat disease-specific morbidity and contrast poor long-term outcomes. Conclusion: This paper describes the Paris consensus on the definitions and diagnostic criteria for seronegative CD and chronic NCEs in adults.